MannKind
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell MannKind and other ETFs, options, and stocks.About MNKD
MannKind Corp. is a biopharmaceutical company, which focuses on the development and commercialization of innovative therapeutic products and devices to address serious unmet medical needs for those living with endocrine and orphan lung diseases. Its products and pipeline include Afrezza, Pediatric Afrezza, V-Go, Tyvaso DPI, MNKD-101, MNKD-201, MNKD-301, and MNKD-501.
CEOMichael E. Castagna
CEOMichael E. Castagna
Employees407
Employees407
HeadquartersDanbury, Connecticut
HeadquartersDanbury, Connecticut
Founded1991
Founded1991
Employees407
Employees407
MNKD Key Statistics
Market cap1.83B
Market cap1.83B
Price-Earnings ratio61.61
Price-Earnings ratio61.61
Dividend yield—
Dividend yield—
Average volume3.17M
Average volume3.17M
High today$6.01
High today$6.01
Low today$5.79
Low today$5.79
Open price$5.83
Open price$5.83
Volume3.39M
Volume3.39M
52 Week high$7.07
52 Week high$7.07
52 Week low$3.38
52 Week low$3.38
Stock Snapshot
MannKind(MNKD) stock is priced at $5.94, giving the company a market capitalization of 1.83B. It carries a P/E multiple of 61.61.
During the trading session on 2025-12-12, MannKind(MNKD) shares reached a daily high of $6.01 and a low of $5.79. At a current price of $5.94, the stock is +2.7% higher than the low and still -1.2% under the high.
Trading volume for MannKind(MNKD) stock has reached 3.39M, versus its average volume of 3.17M.
The stock's 52-week range extends from a low of $3.38 to a high of $7.07.
The stock's 52-week range extends from a low of $3.38 to a high of $7.07.
MNKD News
Simply Wall St 6d
Why MannKind Is Up 6.2% After FDA Accepts FUROSCIX ReadyFlow Autoinjector sNDA FilingMannKind Corporation recently announced that the FDA has accepted its supplemental New Drug Application for the FUROSCIX ReadyFlow Autoinjector, an under-10-sec...
Analyst ratings
100%
of 9 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own MNKD. This list is generated using Robinhood data, and it’s not a recommendation.